SCHEMBL8949571

SCHEMBL8949571

CCCCCCn1ccn(-c2ccc(S(=O)(=O)Cl)cc2)c1=O

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 3/20 0.46
▸ ADRB1 P08588 3/20 0.46
▸ ADRB3 P13945 3/20 0.46
▸ DRD2 P14416 2/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ CYP1A1 P04798 3/20 0.34
▸ CA2 P00918 2/20 0.34
▸ ICMT O60725 2/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ MGLL Q99685 3/20 0.34
▸ FAAH O00519 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ PTGS1 P23219 3/20 0.33
▸ PTGS2 P35354 3/20 0.33
▸ NR1I2 O75469 1/20 0.33
▸ TLR8 Q9NR97 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27471361 0.85 DRD2 (0.43) ADRB2ADRB1ADRB3DRD2DRD3
SCHEMBL27471807 0.78 DRD2 (0.37) ADRB2ADRB1ADRB3DRD2DRD3
SCHEMBL11396212 0.74 DRD2 (0.43) ADRB2ADRB1ADRB3DRD2DRD3
SCHEMBL6678530 0.71 PTGS1 (0.48) MGLLFAAHMAPTPTGS1PTGS2
SCHEMBL7828106 0.70 CYP1A1 (0.64) ADRB2ADRB1ADRB3DRD2DRD3
SCHEMBL8787666 0.70 CYP1A1 (0.64) ADRB2ADRB1ADRB3DRD2DRD3
SCHEMBL25160404 0.69 ALDH1A1 (0.43) DRD2DRD3MGLLMAPT
SCHEMBL282436 0.69 CA2 (0.66) ADRB3CA2CA12CA1CA9
SCHEMBL10609781 0.69 CA2 (0.66) ADRB3CA2CA12CA1CA9
SCHEMBL3684557 0.69 CA2 (0.66) ADRB3CA2CA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1149869-A Substituted sulfonamides as selective beta3 agonists for treatment of diabetes and obesity MERCK & CO LTD (US) 1997-05-14 — — CN disclosed
US-5561142-A Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity MERCK & CO., INC. (US) 1996-10-01 — — US disclosed
US-5541197-A Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity MERCK & CO., INC. (US) 1996-07-30 — — US disclosed
Send feedback